Edmond Dédé's four-act opera, “Morgiane," written in 1888, is the oldest known opera composed by an African American. Sally McKee, now a retired history professor at UC Davis, helped unearth his story in a biography on Dédé in 2017. Now, in 2025, the work is finally being performed in full.

A minimalist work of experimental theater, "Small Mouth Sounds" casts the audience as voyeurs in an entertaining adventure that gradually turns more serious. Set at a rustic retreat, the dramedy, presented by the UC Davis Department of Theatre and Dance, opens Feb. 27 in the Wyatt Pavilion Theatre.

Several faculty at the University of California, Davis, are among the recipients of presidential awards for excellence in STEM mentoring and research announced by the White House Jan. 13 and 14.

A ribbon-cutting ceremony held on January 26, 2025 marked the culmination of a vision made possible by philanthropist Maria Manetti Shrem through her transformative gift of over $20 million to the arts at UC Davis.

The 2025 Templeton Colloquium in Art History at UC Davis — Cultural Heritage at Stake: Between Conservation and Criminality — debates cultural heritage today and explores the stakes for the protection of culture around the globe. 

The University of California, Davis, is pleased to announce the autumn cohort of the Science Translation and Innovative Research (STAIR) Grant Program. The cohort includes Annaliese Franz, a professor in Department of Chemistry.

The Jan Shrem and Maria Manetti Shrem Museum of Art at the University of California, Davis, unveils the first U.S. presentation of Italy’s renowned Sandretto Re Rebaudengo Collection, and the first solo museum exhibition of artist Ruby Neri.

Using his art to comment on social and environmental issues, Enrique Chagoya’s prints, drawings, collages and multiples offer critical commentary on the global reach of the United States and its cultural, political and historical tensions with Latin America. The artist is speaking on Thursday, Jan. 30, for the 2025 Betty Jean and Wayne Thiebaud Endowed Lecture at UC Davis.

Delix Therapeutics recently announced that the first neuroplastogen drug based on UC Davis Institute for Psychedelics and Neurotherapeutics (IPN) research will be tested in patients with major depressive disorder.

The University of California, Davis, welcomed one of its most diverse entering classes and became eligible to be one of the nation’s few research-intensive universities designated as a Hispanic-Serving Institution, or HSI, as it enrolled a record 41,239 students in fall 2024.